Millavelez, Bb Girl .

HRN: 26-06-26  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/02/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
01/02/2025
01/09/2025
IV
82.5mg
Q24hrs
Pcap C
Rejected 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Non-compliant To Guidelines